ResMed Inc. (NYSE:RMD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income increased 23.91% to $77.9 million (53 cents per diluted share) in the quarter versus a net gain of $62.87 million in the year-earlier quarter. Revenue Rose 13.15% to $376.5 million from the year-earlier quarter.
ResMed Inc. reported adjusted net income of 53 cents per share. By that measure, the company beat the mean analyst estimate of $0.51. It beat the average revenue estimate of $363.76 million.